FDA Withdrawn Approval for Some Cholesterol Lowering Drugs
FDA Withdraw The Approval of Niacin and Fenofibric Announced in the Federal Register on April 18, 2016, the U.S. Food and Drug Administration (FDA) disclosed their decision to withdraw earlier approval of niacin and fenofibric acid in combination with statins to treat high cholesterol, according to Medscape. Affected are niacin … [Read more...] about FDA Withdrawn Approval for Some Cholesterol Lowering Drugs
Cholesterol, TB Drugs Recalled in the Philippines Due to Failed Dissolution Tests
Specific lots of cholesterol drugs and a tuberculosis medication are being recalled in the Philippines because laboratory testing shows that they failed to dissolve properly, the Food and Drug Administration (FDA) announced. The recall affects the cholesterol drug simvastatin sold under the brand name Novovast, and includes lot … [Read more...] about Cholesterol, TB Drugs Recalled in the Philippines Due to Failed Dissolution Tests
Study Shows Increased Risk of Type 2 Diabetes for Statin Users
A new study from Finland has confirmed previous findings about a link between the use of cholesterol-lowering statin drugs and higher risk of Type 2 diabetes. This study, published in the journal Diabetologia, avoided some of the limitations of earlier research—selective population, size, self-reporting by participants—that … [Read more...] about Study Shows Increased Risk of Type 2 Diabetes for Statin Users
